Company
ONCOMATRYX BIOPHARMA SL
- Biotech
HQ: 48160
Overview
Oncomatryx develops biotechnology programs focused on modulating the tumor microenvironment. Its work includes clinical trials, OMTX705, next-generation ADC pipeline, and preclinical drug candidates.